{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:53:37Z","timestamp":1790517217987,"version":"4.1.0"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.ejmech.2019.06.018","type":"journal-article","created":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T20:06:11Z","timestamp":1559937971000},"page":"552-570","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Synthesis of novel S-linked dihydroartemisinin derivatives and evaluation of their anticancer activity"],"prefix":"10.1016","volume":"178","author":[{"given":"Rajesh","family":"Gour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faiz","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santosh Kumar","family":"Prajapati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santosh Kumar","family":"Giri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shibendra Kumar","family":"Lal Karna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.P. Ravindranathan","family":"Kartha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1202-5120","authenticated-orcid":false,"given":"Yuba Raj","family":"Pokharel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2019.06.018_bib1","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.actatropica.2005.06.009","article-title":"Artemisinin-based combination therapies (ACTs): best hope for malaria treatment but inaccessible to the needy","volume":"95","author":"Mutabingwa","year":"2005","journal-title":"Acta Trop."},{"key":"10.1016\/j.ejmech.2019.06.018_bib2","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.tips.2008.07.004","article-title":"Artemisinins: their growing importance in medicine","volume":"29","author":"Krishna","year":"2008","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2019.06.018_bib3","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1021\/np50096a007","article-title":"Cytotoxicity of artemisinin-related endoperoxides to Ehrlich ascites tumor cells","volume":"56","author":"Woerdenbag","year":"1993","journal-title":"J.\u00a0Nat. Prod."},{"key":"10.1016\/j.ejmech.2019.06.018_bib4","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00280-017-3251-7","article-title":"Artemisinin, and its derivatives in cancer therapy: status of progress, mechanism of action, and future perspectives","volume":"79","author":"Bhaw-Luximon","year":"2017","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.06.018_bib5","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/CAD.0000000000000054","article-title":"Artemisinin triggers a G1 cell cycle arrest of human Ishikawa endometrial cancer cells and inhibits cyclin-dependent kinase-4 promoter activity and expression by disrupting nuclear factor-\u03baB transcriptional signaling","volume":"25","author":"Tran","year":"2014","journal-title":"Anti Canccer Drugs"},{"key":"10.1016\/j.ejmech.2019.06.018_bib6","doi-asserted-by":"crossref","first-page":"6587","DOI":"10.1074\/jbc.M110.210047","article-title":"Artesunate activates mitochondrial apoptosis in breast cancer cells via iron-catalyzed lysosomal reactive oxygen species production","volume":"286","author":"Hamacher-Brady","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2019.06.018_bib7","doi-asserted-by":"crossref","first-page":"e37222","DOI":"10.1371\/journal.pone.0037222","article-title":"Dihydroartemisinin enhances Apo2l\/TRAIL-mediated apoptosis in pancreatic cancer cells via ROS-mediated up-regulation of death receptor 5","volume":"7","author":"Kong","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2019.06.018_bib8","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.4161\/cbt.7.7.6035","article-title":"Dihydroartemisinin induces apoptosis in HL-60 leukemia cells dependent on iron and p38 mitogen-activated protein kinase activation but independent of reactive oxygen species","volume":"7","author":"Lu","year":"2008","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.ejmech.2019.06.018_bib9","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.yexcr.2015.07.004","article-title":"Artesunate induces apoptosis via a ROS-independent and Bax-mediated intrinsic pathway in Hep G2 cells","volume":"336","author":"Qin","year":"2015","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.ejmech.2019.06.018_bib10","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.3892\/or.2014.3323","article-title":"Artemisinin reduces cell proliferation and induces apoptosis in neuroblastoma","volume":"32","author":"Zhu","year":"2014","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ejmech.2019.06.018_bib11","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1002\/ijc.25315","article-title":"First evidence that the antimalarial drug artesunate inhibits invasion and in\u00a0vivo metastasis in lung cancer by targeting essential extracellular proteases","volume":"127","author":"Rasheed","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ejmech.2019.06.018_bib12","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1158\/1535-7163.MCT-10-0051","article-title":"Dihydroartemisinin induces apoptosis by a Bak-dependent intrinsic pathway","volume":"9","author":"Handrick","year":"2010","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ejmech.2019.06.018_bib13","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.yexcr.2016.06.012","article-title":"Artesunate induces ROS-dependent apoptosis via a Bax-mediated intrinsic pathway in Huh-7 and Hep3B cells","volume":"347","author":"Pang","year":"2016","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.ejmech.2019.06.018_bib14","doi-asserted-by":"crossref","first-page":"14814","DOI":"10.1038\/srep14814","article-title":"Comparison of carbon-sulfur and carbon-amine bond in therapeutic drug: 4\u03b2-S-aromatic heterocyclic podophyllum derivatives display antitumor activity","volume":"5","author":"Li","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2019.06.018_bib15","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/nature04543","article-title":"The prolyl isomerase Pin1 regulates amyloid precursor protein processing and amyloid-\u03b2 production","volume":"440","author":"Pastorino","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2019.06.018_bib16","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.cell.2012.02.016","article-title":"Proline isomer-specific antibodies reveal the early pathogenic tau conformation in Alzheimer's disease","volume":"149","author":"Nakamura","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2019.06.018_bib17","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/cr.2014.109","article-title":"Prolyl isomerase Pin1 in cancer","volume":"24","author":"Lu","year":"2014","journal-title":"Cell Res."},{"key":"10.1016\/j.ejmech.2019.06.018_bib18","doi-asserted-by":"crossref","first-page":"e015r6833","DOI":"10.1371\/journal.pone.0156833","article-title":"Overexpression of PIN1 enhances cancer growth and aggressiveness with cyclin D1 induction in EBV-associated nasopharyngeal carcinoma","volume":"11","author":"Xu","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2019.06.018_bib19","first-page":"6244","article-title":"The prolyl isomerase Pin1 is a novel prognostic marker in human prostate cancer","volume":"63","author":"Ayala","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2019.06.018_bib20","first-page":"393","article-title":"Morphological and immunocytochemical effects of dihydroartemisinin on differentiating NB2a neuroblastoma cells","volume":"19","author":"Fishwick","year":"1998","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.ejmech.2019.06.018_bib21","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1128\/AAC.38.8.1813","article-title":"Neurotoxicity of artemisinin analogs in\u00a0vitro","volume":"38","author":"Wesche","year":"1994","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2019.06.018_bib22","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.2042-7158.1998.tb06173.x","article-title":"The pharmacokinetics and bioavailability of dihydroartemisinin, arteether, artemether, artesunic acid and artelinic acid in rats","volume":"50","author":"Li","year":"1998","journal-title":"J.\u00a0Pharm. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.06.018_bib23","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1039\/b104340b","article-title":"Optimisation of the allylsilane approach to C-10 deoxo carba analogs of dihydroartemisinin: synthesis and in\u00a0vitro antimalarial activity of new, metabolically stable C-10 analogs","volume":"20","author":"O'Neill","year":"2001","journal-title":"J.\u00a0Chem. Soc. Perkin Trans. I"},{"key":"10.1016\/j.ejmech.2019.06.018_bib24","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1080\/07328309808002346","article-title":"Iodine, and its interhalogen compounds: versatile reagents in carbohydrate chemistry V. Synthesis of 1, 2-trans-Linked 1-thioglycosides from the per-O-acetylated glycoses","volume":"17","author":"Kartha","year":"1998","journal-title":"J.\u00a0Carbohydr. Chem."},{"key":"10.1016\/j.ejmech.2019.06.018_bib25","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0008-6215(00)85946-7","article-title":"Synthesis of 1, 2-trans-related 1-thioglycoside esters","volume":"52","author":"Ferrier","year":"1976","journal-title":"Carbohydr. Res."},{"key":"10.1016\/j.ejmech.2019.06.018_bib26","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/S0040-4039(00)76777-3","article-title":"Stereoselective oxidations of a \u03b2-methylglycal, anhydrodihydroartemisinin","volume":"35","author":"Pu","year":"1994","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2019.06.018_bib27","doi-asserted-by":"crossref","first-page":"3683","DOI":"10.1016\/j.bmcl.2004.05.013","article-title":"Synthesis and antiangiogenic activity of exo-olefinated deoxoartemisinin derivatives","volume":"14","author":"Oh","year":"2004","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.06.018_bib28","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/0223-5234(96)88287-0","article-title":"Antimalarial activity of new ethers and thioethers of dihydroartemisinin","volume":"30","author":"Venugopalan","year":"1995","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.06.018_bib29","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1074\/jbc.M804491200","article-title":"Artemisinin blocks prostate cancer growth and cell cycle progression by disrupting Sp1 interactions with the cyclin-dependent kinase-4 (CDK4) promoter and inhibiting CDK4 gene expression","volume":"284","author":"Willoughby","year":"2009","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2019.06.018_bib30","doi-asserted-by":"crossref","first-page":"5519","DOI":"10.1158\/1078-0432.CCR-08-0197","article-title":"Experimental therapy of hepatoma with artemisinin and its derivatives: in\u00a0vitro and in\u00a0vivo activity, chemosensitization, and mechanisms of action","volume":"14","author":"Hou","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejmech.2019.06.018_bib31","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s10495-013-0857-z","article-title":"Artemisinin induces A549 cell apoptosis dominantly via a reactive oxygen species-mediated amplification activation loop among caspase-9,-8 and-3","volume":"18","author":"Gao","year":"2013","journal-title":"Apoptosis"},{"key":"10.1016\/j.ejmech.2019.06.018_bib32","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.fob.2012.05.002","article-title":"Dihydroartemisinin induces autophagy and inhibits the growth of iron-loaded human myeloid leukemia K562 cells via ROS toxicity","volume":"2","author":"Wang","year":"2012","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.ejmech.2019.06.018_bib33","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.drup.2004.01.004","article-title":"ROS stress in cancer cells and therapeutic implications","volume":"7","author":"Pelicano","year":"2004","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.ejmech.2019.06.018_bib34","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1158\/0008-5472.CAN-07-5259","article-title":"Oxidative stress is inherent in prostate cancer cells and is required for aggressive phenotype","volume":"68","author":"Kumar","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2019.06.018_bib35","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1023\/A:1009616228304","article-title":"Role of reactive oxygen species (ROS) in apoptosis induction","volume":"5","author":"Simon","year":"2000","journal-title":"Apoptosis"},{"key":"10.1016\/j.ejmech.2019.06.018_bib36","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/00001622-200011000-00006","article-title":"Regulation of Bcl-xL: a little bit of this and a little bit of STAT","volume":"12","author":"Grad","year":"2000","journal-title":"Curr. Opin. Oncol."},{"key":"10.1016\/j.ejmech.2019.06.018_bib37","first-page":"6052","article-title":"Bcl-xL in prostate cancer cells: effects of overexpression and down-regulation on chemosensitivity","volume":"60","author":"Lebedeva","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2019.06.018_bib38","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1046\/j.1440-1827.2002.01343.x","article-title":"Matrix metalloproteinases in tumor invasion: role for cell migration","volume":"52","author":"Nabeshima","year":"2002","journal-title":"Pathol. Int."},{"key":"10.1016\/j.ejmech.2019.06.018_bib39","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/sj.pcan.4500750","article-title":"Type IV collagenase (matrix metalloproteinase-2 and-9) in prostate cancer","volume":"7","author":"Zhang","year":"2004","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"10.1016\/j.ejmech.2019.06.018_bib40","doi-asserted-by":"crossref","first-page":"7245","DOI":"10.1073\/pnas.94.14.7245","article-title":"Distinct roles for E2F proteins in cell growth control and apoptosis","volume":"94","author":"DeGregori","year":"1997","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.ejmech.2019.06.018_bib41","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/nature07310","article-title":"E2F1 represses \u03b2-catenin transcription and is antagonized by both pRB and CDK8","volume":"455","author":"Morris","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2019.06.018_bib42","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/gb-2003-4-9-117","article-title":"Comparing protein abundance and mRNA expression levels on a genomic scale","volume":"4","author":"Greenbaum","year":"2003","journal-title":"Genome Biol."},{"key":"10.1016\/j.ejmech.2019.06.018_bib43","doi-asserted-by":"crossref","first-page":"5281","DOI":"10.1128\/MCB.22.15.5281-5295.2002","article-title":"PIN1 is an E2F target gene essential for Neu\/Ras-induced transformation of mammary epithelial cells","volume":"22","author":"Ryo","year":"2002","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ejmech.2019.06.018_bib44","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1186\/1476-4598-6-24","article-title":"The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention","volume":"6","author":"Alao","year":"2007","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ejmech.2019.06.018_bib45","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1093\/emboj\/20.13.3459","article-title":"Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c-Jun towards cyclin D1","volume":"20","author":"Wulf","year":"2001","journal-title":"EMBO J."},{"key":"10.1016\/j.ejmech.2019.06.018_bib46","first-page":"491","article-title":"Pin1 contributes to cervical tumorigenesis by regulating cyclin D1 expression","volume":"16","author":"Li","year":"2006","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ejmech.2019.06.018_bib47","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1073\/pnas.032404099","article-title":"Loss of Pin1 function in the mouse causes phenotypes resembling cyclin D1-null phenotypes","volume":"99","author":"Liou","year":"2002","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.ejmech.2019.06.018_bib48","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1093\/emboj\/19.9.2056","article-title":"Cell cycle-dependent variations in c-Jun and JunB phosphorylation: a role in the control of cyclin D1 expression","volume":"19","author":"Bakiri","year":"2000","journal-title":"EMBO J."},{"key":"10.1016\/j.ejmech.2019.06.018_bib49","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/emboj\/18.1.188","article-title":"c-Jun regulates cell cycle progression and apoptosis by distinct mechanisms","volume":"18","author":"Wisdom","year":"1999","journal-title":"EMBO J."},{"key":"10.1016\/j.ejmech.2019.06.018_bib50","doi-asserted-by":"crossref","first-page":"E131","DOI":"10.1038\/ncb0502-e131","article-title":"AP-1 as a regulator of cell life and death","volume":"4","author":"Shaulian","year":"2002","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ejmech.2019.06.018_bib51","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ejcb.2013.10.003","article-title":"AP-1\/c-Jun transcription factors: regulation and function in malignant melanoma","volume":"93","author":"Kappelmann","year":"2014","journal-title":"Eur. J. Cell Biol."},{"key":"10.1016\/j.ejmech.2019.06.018_bib52","doi-asserted-by":"crossref","first-page":"8","DOI":"10.25011\/cim.v31i1.3136","article-title":"Ki-67 and PCNA expression in prostate cancer and benign prostatic hyperplasia","volume":"31","author":"Zhong","year":"2008","journal-title":"Clin. Investig. Med."},{"key":"10.1016\/j.ejmech.2019.06.018_bib53","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.bcp.2010.02.016","article-title":"Dihydroartemisinin accelerates c-MYC oncoprotein degradation and induces apoptosis in c-MYC-overexpressing tumor cells","volume":"80","author":"Lu","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.06.018_bib54","doi-asserted-by":"crossref","first-page":"524","DOI":"10.7150\/ijms.11352","article-title":"Artesunate induces SKM-1 cells apoptosis by inhibiting hyperactive \u03b2-catenin signaling pathway","volume":"12","author":"Xu","year":"2015","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.ejmech.2019.06.018_bib55","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1177\/1947601910379132","article-title":"MYC and prostate cancer","volume":"1","author":"Koh","year":"2010","journal-title":"Genes & Cancer"},{"key":"10.1016\/j.ejmech.2019.06.018_bib56","doi-asserted-by":"crossref","first-page":"4754","DOI":"10.1128\/MCB.16.9.4754","article-title":"An essential E box in the promoter of the gene encoding the mRNA cap-binding protein (eukaryotic initiation factor 4E) is a target for activation by c-myc","volume":"16","author":"Jones","year":"1996","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ejmech.2019.06.018_bib57","first-page":"971","article-title":"Translation initiation in cancer: a novel target for therapy","volume":"1","author":"Meric","year":"2002","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ejmech.2019.06.018_bib58","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/nature02369","article-title":"Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy","volume":"428","author":"Wendel","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2019.06.018_bib59","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1080\/15384101.2016.1201253","article-title":"c-Myc is a novel target of cell cycle arrest by honokiol in prostate cancer cells","volume":"15","author":"Hahm","year":"2016","journal-title":"Cell Cycle"},{"issue":"2009","key":"10.1016\/j.ejmech.2019.06.018_bib60","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nrc2657","article-title":"p21 in cancer: intricate networks and multiple activities","volume":"9","author":"Abbas","year":"2009","journal-title":"Nat. Rev. Canc."},{"key":"10.1016\/j.ejmech.2019.06.018_bib61","doi-asserted-by":"crossref","first-page":"36966","DOI":"10.1074\/jbc.M212517200","article-title":"p21\/CDKN1A mediates negative regulation of transcription by p53","volume":"278","author":"Lohr","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2019.06.018_bib62","doi-asserted-by":"crossref","first-page":"36966","DOI":"10.1074\/jbc.M305178200","article-title":"Cdk2-dependent phosphorylation of the NF-Y transcription factor and its involvement in the p53-p21 signaling pathway","volume":"278","author":"Yun","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2019.06.018_bib63","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/(SICI)1521-1878(199803)20:3<195::AID-BIES2>3.0.CO;2-R","article-title":"PCNA binding through a conserved motif","volume":"20","author":"Warbrick","year":"1998","journal-title":"Bioessays"},{"key":"10.1016\/j.ejmech.2019.06.018_bib64","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1038\/ncb1499","article-title":"Hierarchical regulation of mitochondrion-dependent apoptosis by BCL-2 subfamilies","volume":"8","author":"Kim","year":"2006","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ejmech.2019.06.018_bib65","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1101\/gad.1304105","article-title":"Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins","volume":"19","author":"Willis","year":"2005","journal-title":"Genes Dev."},{"key":"10.1016\/j.ejmech.2019.06.018_bib66","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1158\/1535-7163.MCT-08-0333","article-title":"Natural BH3 mimetic (-)-gossypol chemosensitizes human prostate cancer via Bcl-xL inhibition accompanied by increase of Puma and Noxa","volume":"7","author":"Meng","year":"2008","journal-title":"Mol. Cancer Ther."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419305379?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419305379?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T13:59:03Z","timestamp":1759327143000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523419305379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":66,"alternative-id":["S0223523419305379"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.06.018","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis of novel S-linked dihydroartemisinin derivatives and evaluation of their anticancer activity","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.06.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}